IPF Pharmacology Case Study: Operational Excellence Drives Healthy Volunteer To Patient Cohort Results in 24 Months for Rare Respiratory Disease

The biotech sponsor needed to demonstrate the safety and tolerability of the lead molecule in healthy volunteers, as well as direct target engagement and biomarker effects for IPF patients in a short space of time.

Back to Case Studies Archive